Vodobatinib
98%
- Product Code: 245537
Alias:
2-Chloro-6-methyl-N'-(4-methyl-3-(quinoline-3-ylethynyl)benzoyl)benzoylhydrazide
CAS:
1388803-90-4
| Molecular Weight: | 453.92 g./mol | Molecular Formula: | C₂₇H₂₀ClN₃O₂ |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | -20°C |
Product Description:
Used in research for targeted cancer therapy, particularly in inhibiting tyrosine kinases involved in tumor growth and proliferation. Shows potential in treating cancers with specific genetic mutations, especially in hematologic malignancies and solid tumors. Its selectivity helps minimize damage to healthy cells, making it a candidate for precision medicine approaches. Also investigated for overcoming resistance to earlier-generation kinase inhibitors.
Sizes / Availability / Pricing:
| Size | Availability | Price | Quantity |
|---|---|---|---|
| 0.025 | 10-20 days | $897.39 |
+
-
|
| 0.005 | 10-20 days | $408.86 |
+
-
|
Vodobatinib
Used in research for targeted cancer therapy, particularly in inhibiting tyrosine kinases involved in tumor growth and proliferation. Shows potential in treating cancers with specific genetic mutations, especially in hematologic malignancies and solid tumors. Its selectivity helps minimize damage to healthy cells, making it a candidate for precision medicine approaches. Also investigated for overcoming resistance to earlier-generation kinase inhibitors.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Purchase History for
Loading purchase history...
Cart
No products
Subtotal:
$0.00
$0.00
Total :